title: T2 shortening in the visual cortex: effect of aging and cerebrovascular disease.
abstract: OBJECTIVE
  To evaluate the effect of aging and cerebrovascular disease on T2 shortening in the visual cortex at MR imaging.
  
  
  METHODS
  MR images of 72 neurologically normal subjects (45 men and 27 women, 35 to 92 years old) and 32 (13 men and 19 women, 54 to 92 years old) with cerebrovascular disease were evaluated retrospectively. On T2-weighted spin-echo images, the signal intensity of the visual, motor, and sensory cortices was divided into three grades and compared with the signal intensity of the frontal subcortical white matter.
  
  
  RESULTS
  Decreased signal intensity (grade III) was rarely seen in the visual and sensory cortices of the neurologically normal subjects who were less than 60 years old. The signal intensity of the motor cortex decreased rapidly after the age of 50 years. At 61 to 70 years of age, 53% of these subjects had grade III intensity, and at age 71 years or older, 94% had reached grade III. The frequency of progression from grade I to grade III was lower in the visual cortex than in the motor cortex; 22% of these subjects had grade III appearance at age 61 to 70 years, and at age 71 years older, 56% had reached grade III. In patients with cerebrovascular disease who were older than 60 years of age, the frequency of grade III signal intensity in the visual cortex was almost equal to that in the neurologically normal subjects.
  
  
  CONCLUSIONS
  T2 shortening in the visual cortex is frequently seen in neurologically normal older persons. These findings are compatible with a previously reported histochemical study of normal iron deposition in the visual cortex. Cerebrovascular disease has no effect on T2 shortening in the visual cortex.
authors.affiliation: Department of Radiology, Kumamoto University, School of Medicine, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Korogi
authors.forename: T
authors.initials: T
authors.lastname: Hirai
authors.forename: Y
authors.initials: Y
authors.lastname: Komohara
authors.forename: T
authors.initials: T
authors.lastname: Okuda
authors.forename: I
authors.initials: I
authors.lastname: Ikushima
authors.forename: M
authors.initials: M
authors.lastname: Kitajima
authors.forename: Y
authors.initials: Y
authors.lastname: Shigematu
authors.forename: T
authors.initials: T
authors.lastname: Sugahara
authors.forename: M
authors.initials: M
authors.lastname: Takahashi
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000473:pathology*; D001480:Basal Ganglia Diseases / Q000473:pathology; D002544:Cerebral Infarction / Q000473:pathology; D002561:Cerebrovascular Disorders / Q000473:pathology*; D005260:Female; D005625:Frontal Lobe / Q000473:pathology; D006651:Histocytochemistry; D006801:Humans; D007501:Iron / Q000378:metabolism; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009044:Motor Cortex / Q000473:pathology; D012189:Retrospective Studies; D013003:Somatosensory Cortex / Q000473:pathology; D014793:Visual Cortex / Q000378:metabolism / Q000473:pathology*
chemical_list: D007501:Iron